IMI INTERNATIONAL MEDICAL INNOVATIONS INC - Notice of Conference
Call [470]
Canadian Market News from Market News Publishing, Monday, December 11, 2000
at 12:21
IMI International Medical Innovations Inc. will release its fiscal
2001 third-quarter financial results on Friday morning, December 15. With
the release of these results, IMI is initiating the practice of holding
quarterly conference calls for its investors and others interested in
following the company's progress.
The conference call will be chaired by IMI's President and CEO, Dr.
Brent Norton, and will include Ron Hosking, Vice-President and Chief
Financial Officer, and Andrew Weir, Director, Communications.
Time: 11:00 a.m. Eastern Time
Date: Friday, December 15, 2000
Conference Call No.: 888-666-4830
Please call five minutes prior to the 11:00 a.m. start.
If you are unable to participate at that time, you may call
800-558-5253 (U.S. & Canada), then enter Reservation Number 17155225 from
1:00 p.m. on December 15 through December 22 to hear a recording of the
entire call.
IMI is a Canadian and world leader in predictive medicine, dedicated to
developing innovative products for the rapid and early detection of
life-threatening conditions, particularly cardiovascular disease and
cancer. The Company's lead products are Cholesterol 1,2,3(TM), a
three-minute test that measures cholesterol on the skin (on the palm of
the hand), and ColorectAlert(TM), a test for early-stage colorectal
cancer. IMI is located in Toronto, with shares currently traded on the
Toronto Stock Exchange (TSE:IMI - 18,505,199 shares outstanding).
TEL: (416) 222-3449 x 27 Mr. Andrew Weir, Director, Communications
Email: aweir@imin.ca
Web site: www.imin.ca
(c) Market News Publishing Inc. Tel:(604) 689-1101
All rights reserved. Fax:(604) 689-1106
MarketbyFax(tm) - To get the NEWS as it happens, call (604) 689-3041.
Companies or Securities discussed in this article:
Symbol
Name
BB:IMINF
TSE:IMI
IMI International Medical Innovations
Inc. J |
